Thyroid cancer after in vitro fertilization: a retrospective, non-consecutive case-series analysis

References

• Ceresini G, Corcione L, Michiara M, et al. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. Cancer 2012;118:5473–80
   Google Scholar
• Londero SC, Krogdahl A, Bastholt L, et al. Papillary thyroid carcinoma in Denmark 1996–2008: an investigation of changes in incidence. Cancer Epidemiol 2013;37:e1–6
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295:2164–7
   PubMed Web of Science ®Google Scholar
• Reynolds RM, Weir J, Stockton DL, et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 2005;62:156–62
   PubMed Web of Science ®Google Scholar
• Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801–7
   PubMed Web of Science ®Google Scholar
• McNally RJ, Blakey K, James PW, et al. Increasing incidence of thyroid cancer in Great Britain, 1976–2005: age-period-cohort analysis. European J Epidemiol 2012;27:615–22
   Web of Science ®Google Scholar
• Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2006. http://seercancergov/csr/1975_2006/ [last accessed 2012]
   Google Scholar
• Horn-Ross PL, Chang ET, Clarke CA, et al. Nativity and papillary thyroid cancer incidence rates among Hispanic women in California. Cancer 2012;118:216–22
   Google Scholar
• Brindel P, Doyon F, Rachedi F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008;167:219–29
   PubMed Web of Science ®Google Scholar
• Rossing MA, Voigt LF, Wicklund KG, et al. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765–72
   Google Scholar
• Di Vito M, De Santis E, Perrone GA, et al. Overexpression of estrogen receptor-alpha in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology. Cancer Sci 2011;102:1921–7
   Google Scholar
• Kansakar E, Chang YJ, Mehrabi M, et al. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer. AmSurgeon 2009;75:785–9 (discussion 789)
   Google Scholar
• Magri F, Capelli V, Rotondi M, et al. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. Endocrine-related cancer 2012;19:463–71
   Google Scholar
• Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586–90
   PubMed Web of Science ®Google Scholar
• Brinton LA, Scoccia B, Moghissi KS, et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004;19:2005–13
   PubMed Web of Science ®Google Scholar
• Brinton LA, Lamb EJ, Moghissi KS, et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 2004;103:1194–203
   PubMed Web of Science ®Google Scholar
• Althuis MD, Scoccia B, Lamb EJ, et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 2005;193:668–74
   PubMed Web of Science ®Google Scholar
• Jensen A, Sharif H, Olsen JH, et al. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J Epidemiol 2008;168:49–57
   PubMedGoogle Scholar
• Kallen B, Finnstrom O, Lindam A, et al. Malignancies among women who gave birth after in vitro fertilization. Human reproduction 2011;26:253–8
   PubMed Web of Science ®Google Scholar
• Doyle P, Maconochie N, Beral V, et al. Cancer incidence following treatment for infertility at a clinic in the UK. Human reproduction 2002;17:2209–13
   PubMed Web of Science ®Google Scholar
• Gauthier E, Paoletti X, Clavel-Chapelon F, et al. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Human reproduction 2004;19:2216–21
   PubMed Web of Science ®Google Scholar
• Hannibal CG, Jensen A, Sharif H, et al. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 2008;23:451–6
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer causes & control: CCC 1999;10:157–66
   PubMedGoogle Scholar
• Dor J, Lerner-Geva L, Rabinovici J, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324–7
   PubMed Web of Science ®Google Scholar
• McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab 2012;97:2682–92
   PubMed Web of Science ®Google Scholar
• Yli-Kuha AN, Gissler M, Klemetti R, et al. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 2012;27:1149–55
   PubMed Web of Science ®Google Scholar
• Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor – a review. Placenta 2008;29:169–77
   PubMedGoogle Scholar
• Brinton LA, Westhoff CL, Scoccia B, et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 2005;16:500–7
   PubMed Web of Science ®Google Scholar
• Dekkers OM, Egger M, Altman DG, et al. Distinguishing case series from cohort studies. Ann Intern Med 2012;156:37–40
   PubMed Web of Science ®Google Scholar
• Chen YK, Lin CL, Cheng FT, et al. Cancer risk in patients with Hashimoto's thyroiditis: a nationwide cohort study. Br J Cancer 2013;109:2496–501
   Google Scholar
• Vaiman M, Olevson Y, Habler L, et al. The estrogen receptors in the papillary carcinoma of the thyroid gland. Oncol Res 2010;18:537–40
   Google Scholar
• Davis PJ, Lin HY, Mousa SA, et al. Overlapping nongenomic and genomic actions of thyroid hormone and steroids. Steroids 2011;76:829–33
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL. Approach to the pregnant patient with thyroid cancer. The J Clin Endocrinol Metab 2011;96:265–72
   Google Scholar
• Negro R, Valcavi R, Toulis KA. Incidental thyroid cancer in toxic and nontoxic goiter: is TSH associated with malignany rate? Results of a meta-analysis. Endocr Pract 2013;19:212–18
   Google Scholar